Abstract:Transforming growth factor-β (TGF-β) is a secreted multifunctional factor that plays a key role in intercellular communication. Perturbations of TGF-β signaling can lead to breast cancer. TGF-β elicits its effects on proliferation and differentiation via specific cell surface TGF-β type I and type II receptors (i.e., TβRI and TβRII) that contain an intrinsic serine/threonine kinase domain. Upon TGF-β-induced heteromeric complex formation, activated TβRI elicits intracellular signaling by phosphorylating SMAD2 and SMAD3. These activated SMADs form heteromeric complexes with SMAD4 to regulate specific target genes, including plasminogen activation inhibitor 1 (PAI-1, encoded by the SERPINE1 gene). The induction of epithelial-to-mesenchymal transition (EMT) allows epithelial cancer cells at the primary site or during colonization at distant sites to gain an invasive phenotype and drive tumor progression. TGF-β acts as a potent inducer of breast cancer invasion by driving EMT. Here, we describe systematic methods to investigate TGF-β signaling and EMT responses using premalignant human MCF10A-RAS (M2) cells and mouse NMuMG epithelial cells as examples. We describe methods to determine TGF-β-induced SMAD2 phosphorylation by Western blotting, SMAD3/SMAD4-dependent transcriptional activity using luciferase reporter activity and SERPINE1 target gene expression by quantitative real-time-polymerase chain reaction (qRT-PCR). In addition, methods are described to examine TGF-β-induced EMT by measuring changes in morphology, epithelial and mesenchymal marker expression, filamentous actin staining and immunofluorescence staining of E-cadherin. Two selective small molecule TGF-β receptor kinase inhibitors, GW788388 and SB431542, were used to block TGF-β-induced SMAD2 phosphorylation, target genes and changes in EMT marker expression. Moreover, we describe the transdifferentiation of mesenchymal breast Py2T murine epithelial tumor cells into adipocytes. Methods to examine TGF-β-induced signaling and EMT in breast cancer may contribute to new therapeutic approaches for breast cancer.

TGF-β1 Regulates the Invasive and Metastatic Potential of Mucoepidermoid Carcinoma Cells.

MicroRNA-182 Targets SMAD7 to Potentiate TGFβ-induced Epithelial-Mesenchymal Transition and Metastasis of Cancer Cells.

Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.

Mucin1 Promotes the Migration and Invasion of Hepatocellular Carcinoma Cells Via JNK-mediated Phosphorylation of Smad2 at the C-terminal and Linker Regions

Inhibition of TGF-β by siRNA Suppresses the Motility and Invasiveness of T24 Bladder Cancer Cells

Transforming Growth Factor-Β1 Promotes Lung Adenocarcinoma Invasion and Metastasis by Epithelial-to-mesenchymal Transition

The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis

TGFβ1I1 Suppressed Cell Migration and Invasion in Colorectal Cancer by Inhibiting the TGF-β Pathway and EMT Progress.

Transforming Growth Factor-Β and Epithelial–mesenchymal Transition Are Associated with Pulmonary Metastasis in Adenoid Cystic Carcinoma

Tgf-Beta 1 Promotes Migration and Invasion of Salivary Adenoid Cystic Carcinoma

[Expression of Mucin 1 and Tumor Invasiveness in Breast Carcinoma].

Transforming growth factor‑β1 induces epithelial‑mesenchymal transition and increased expression of matrix metalloproteinase‑16 via miR‑200b downregulation in bladder cancer cells.

Effects of TGF-β1 Shrna in Proliferation and Adhesion of Human Salivary Gland Mucoepidermoid Carcinoma Cell Ms in Vitro

Blockade of Transforming Growth Factor-β Signaling Suppresses Progression of Androgen-Independent Human Prostate Cancer in Nude Mice

Transforming Growth Factor-Β1 Regulates Epithelial-Mesenchymal Transition in Association with Cancer Stem-Like Cells in a Breast Cancer Cell Line.

Interference of Mucin 1 Inhibits Progression of Colon Carcinoma by Repression of Wnt/β-catenin Signaling.

Mir-335-5p Inhibits TGF-β1-induced Epithelial–mesenchymal Transition in Non-Small Cell Lung Cancer Via ROCK1

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.

TGF-β1 Alters Microrna Profile in Human Gastric Cancer Cells.

TGF-β1 Mediates Epithelial to Mesenchymal Transition Via the TGF-β/Smad Pathway in Squamous Cell Carcinoma of the Head and Neck.

Expression of TGF-β1 and the mechanism of invasiveness and metastasis induced by TGF-β1 in breast cancer